{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:58:13Z","timestamp":1772726293161,"version":"3.50.1"},"reference-count":98,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Policy and Practice"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/20523211.2024.2369319","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T05:06:46Z","timestamp":1722229606000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Use and misuse of psychoactive medicines: a descriptive cross-sectional study in a densely populated region of Portugal"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4328-4341","authenticated-orcid":false,"given":"Ana","family":"Carmona Ara\u00fajo","sequence":"first","affiliation":[{"name":"iMed.ULisboa \u2013 Research Institute for Medicines, University of Lisbon","place":["Lisbon, Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0690-4484","authenticated-orcid":false,"given":"Jos\u00e9 Pedro","family":"Guerreiro","sequence":"additional","affiliation":[{"name":"Centre for Health Evaluation & Research\/Infosa\u00fade \u2013 National Association of Pharmacies (CEFAR\/IS-ANF)","place":["Lisbon, Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6636-5657","authenticated-orcid":false,"given":"Carolina","family":"Bulhosa","sequence":"additional","affiliation":[{"name":"Centre for Health Evaluation & Research\/Infosa\u00fade \u2013 National Association of Pharmacies (CEFAR\/IS-ANF)","place":["Lisbon, Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0562-2514","authenticated-orcid":false,"given":"Filipa","family":"Alves da Costa","sequence":"additional","affiliation":[{"name":"iMed.ULisboa \u2013 Research Institute for Medicines, University of Lisbon","place":["Lisbon, Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2851-2003","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Goul\u00e3o","sequence":"additional","affiliation":[{"name":"ICAD \u2013 Institute on Addictive Behaviours and Dependencies, P.I.","place":["Lisbon, Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3988-1162","authenticated-orcid":false,"given":"Ana Paula","family":"Martins","sequence":"additional","affiliation":[{"name":"Independent expert"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"e_1_3_4_2_1","volume-title":"Bilhete de identidade dos indicadores utilizados na contratualiza\u00e7\u00e3o dos ACES, USF e UCSP","author":"Administra\u00e7\u00e3o Central dos Sistemas de Sa\u00fade","year":"2012","unstructured":"Administra\u00e7\u00e3o Central dos Sistemas de Sa\u00fade. (2012). Bilhete de identidade dos indicadores utilizados na contratualiza\u00e7\u00e3o dos ACES, USF e UCSP. Minist\u00e9rio Da Sa\u00fade."},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18372"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-060519"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/14659891.2023.2213325"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874473710801030255"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.10223"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000557"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2019.1595953"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2015.05.001"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1159\/000348260"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2009.180646"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.20344\/amp.19254"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/ijph.2022.1604755"},{"key":"e_1_3_4_15_1","unstructured":"Cartagena F. J. Porter L. McManus S. Strang J. Hickman M. Reed K. & Smith N. (2017). Prescribing patterns in dependence forming medicines. http:\/\/phrc.lshtm.ac.uk\/"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000337028"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1291"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15050565"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2559"},{"key":"e_1_3_4_20_1","unstructured":"Conselho Nacional de Sa\u00fade. (2019). Sem mais tempo a perder \u2013 Sa\u00fade mental em Portugal: um desafio para a pr\u00f3xima d\u00e9cada. CNS 1\u2013130. https:\/\/fronteirasxxi.pt\/wp-content\/uploads\/2020\/02\/\u201cSem-mais-tempo-a-perder\u201d-CNS-2019.pdf"},{"key":"e_1_3_4_21_1","unstructured":"Conselho Nacional de \u00c9tica para as Ci\u00eancias da Vida. (2023). Parecer 123\/CNECV\/2023 sobre o uso off-label de medicamentos \u2013 Implica\u00e7\u00f5es \u00e9ticas."},{"key":"e_1_3_4_22_1","unstructured":"Coordena\u00e7\u00e3o Nacional da Estrat\u00e9gia do Medicamento e dos Produtos de Sa\u00fade. (2017). Sobreutiliza\u00e7\u00e3o das Benzodiazepinas e dos Z-Hipn\u00f3ticos na Ansiedade e na Ins\u00f3nia. Minist\u00e9rio Da Sa\u00fade. https:\/\/www.ordemfarmaceuticos.pt"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-019-00915-2"},{"key":"e_1_3_4_24_1","first-page":"1","article-title":"Tratamento sintom\u00e1tico da ansiedade e ins\u00f3nia com benzodiazepinas e f\u00e1rmacos an\u00e1logos","author":"Dire\u00e7\u00e3o Geral da Sa\u00fade","year":"2015","unstructured":"Dire\u00e7\u00e3o Geral da Sa\u00fade. (2015). Tratamento sintom\u00e1tico da ansiedade e ins\u00f3nia com benzodiazepinas e f\u00e1rmacos an\u00e1logos. Normas de Orienta\u00e7\u00e3o Cl\u00ednica, 55\/2011, 1\u201310.","journal-title":"Normas de Orienta\u00e7\u00e3o Cl\u00ednica, 55\/2011"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13892"},{"key":"e_1_3_4_26_1","unstructured":"EMCDDA. (2023). Spotlight on\u2009\u2026\u2009Non-medical use of benzodiazepines. 2023. https:\/\/www.emcdda.europa.eu\/spotlights\/non-medical-use-benzodiazepines_en"},{"key":"e_1_3_4_27_1","unstructured":"European Medicines Agency. (2017). Good pharmacovigilance practices \u2013 Annex 1 definitions (Rev.4). Good Pharmacovigilance Practices. https:\/\/www.ema.europa.eu\/en\/human-regulatory\/post-authorisation\/pharmacovigilance\/good-pharmacovigilance-practices#final-gvp-annex-i\u2014definitions-section"},{"key":"e_1_3_4_28_1","unstructured":"European Medicines Agency. (2023). Guideline on clinical investigation of medicinal products in the treatment of depression. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-clinical-investigation-medicinal-products-treatment-depression-revision-3_en.pdf"},{"key":"e_1_3_4_29_1","first-page":"1","article-title":"Estrat\u00e9gias para a descontinua\u00e7\u00e3o de benzodiazepinas","author":"Faria Vaz A.","year":"2017","unstructured":"Faria Vaz, A., Magalh\u00e3es, A. S., Louren\u00e7o, A., Costa, J., Guerreiro, M., & Ribeiro, N. (2017a). Estrat\u00e9gias para a descontinua\u00e7\u00e3o de benzodiazepinas. Boletim Terap\u00eautico \u2013 ARS LVT, Anexo I, 1\u20139.","journal-title":"Boletim Terap\u00eautico \u2013 ARS LVT, Anexo I"},{"key":"e_1_3_4_30_1","first-page":"1","article-title":"Utiliza\u00e7\u00e3o de Benzodiazepinas: Um grave problema de sa\u00fade p\u00fablica","volume":"1","author":"Faria Vaz A.","year":"2017","unstructured":"Faria Vaz, A., Magalh\u00e3es, A. S., Louren\u00e7o, A., Costa, J., Guerreiro, M., & Ribeiro, N. (2017b). Utiliza\u00e7\u00e3o de Benzodiazepinas: Um grave problema de sa\u00fade p\u00fablica. Boletim Terap\u00eautico \u2013 ARS LVT, 1, 1\u20136.","journal-title":"Boletim Terap\u00eautico \u2013 ARS LVT"},{"key":"e_1_3_4_31_1","unstructured":"FDA. (2016 August 31). FDA requires strong warnings for opioid analgesics prescription opioid cough products and benzodiazepine labeling related to serious risks and death from combined use | FDA. FDA News Release. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-requires-strong-warnings-opioid-analgesics-prescription-opioid-cough-products-and-benzodiazepine"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmac037"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1159\/000439273"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.2010.00882.x"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.v118.12"},{"key":"e_1_3_4_36_1","unstructured":"Ghent University \u2013 Faculty of Pharmaceutical Sciences. (2023). Ghent Older People\u2019s Prescriptions community Pharmacy Screening (GheOP3S)-tool \u2013 Version 2. 390. https:\/\/www.ugent.be\/fw\/nl\/onderzoek\/bioanalyse\/farmzorg\/tools\/gheop3s-tool-versie-2\/gheop3s-tool-update_eng\/view"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.20344\/amp.18680"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-020-00985-6"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14014"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-02622-9"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13564"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14397"},{"key":"e_1_3_4_43_1","unstructured":"INFARMED. (2017). Benzodiazepinas e An\u00e1logos. Infarmed. http:\/\/www.infarmed.pt\/documents\/15786\/2219894\/Utliliza\u00e7\u00e3o+de+Benzodiazepinas+e+an\u00e1logos\/adb100fa-4a77-4eb7-9e67-99229e13154f"},{"key":"e_1_3_4_44_1","first-page":"26","article-title":"Psicof\u00e1rmacos na \u00faltima d\u00e9cada em Portugal","volume":"71","author":"INFARMED","year":"2020","unstructured":"INFARMED. (2020). Psicof\u00e1rmacos na \u00faltima d\u00e9cada em Portugal. INFARMED Not\u00edcias, 71, 26\u201329. https:\/\/www.infarmed.pt\/web\/infarmed\/institucional\/documentacao_e_informacao\/publicacoes\/institucionais\/infarmed_noticias\/infarmed-noticias-arquivo","journal-title":"INFARMED Not\u00edcias"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(19)30128-8"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10788-7"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2314"},{"issue":"4","key":"e_1_3_4_48_1","first-page":"33","article-title":"Prescription opioid use and opioid-related mortality monitoring in Slovenia","volume":"24","author":"Kostnapfel T.","year":"2022","unstructured":"Kostnapfel, T., Jandl, M., Hocevar Grom, A., Korosec, A., & Kastelic, A. (2022). Prescription opioid use and opioid-related mortality monitoring in Slovenia. Heroin Addiction and Related Clinical Problems, 24(4), 33\u201339.","journal-title":"Heroin Addiction and Related Clinical Problems"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2015.09.003"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4551"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3532"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-020-02339-7"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.03060.x"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S241780"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33765-0"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.802"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/aas.12594"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.2515\/therapie\/2015013"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.07.012"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1515\/sjpain-2018-0307"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4168"},{"issue":"1","key":"e_1_3_4_62_1","first-page":"89","article-title":"Doctor shopping reveals geographical variations in opioid abuse","volume":"16","author":"Nordmann S.","year":"2013","unstructured":"Nordmann, S., Pradel, V., Lapeyre-Mestre, M., Frauger, E., Pauly, V., Thirion, X., Mallaret, M., Jouanjus, E., & Micallef, J. (2013). Doctor shopping reveals geographical variations in opioid abuse. Pain Physician, 16(1), 89\u2013100.","journal-title":"Pain Physician"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-0909-3"},{"key":"e_1_3_4_64_1","volume-title":"Health at a Glance: Europe 2020","author":"OECD","year":"2020","unstructured":"OECD. (2020). Health at a Glance: Europe 2020. OECD Publishing."},{"key":"e_1_3_4_65_1","unstructured":"OECD. (2023). Pharmaceutical market | OECD Health Statistics | OECD iLibrary. https:\/\/www.oecd.org\/els\/health-systems\/health-data.htm"},{"key":"e_1_3_4_66_1","unstructured":"OECD European Observatory on Health Systems and Policies. (2023). Country health profile 2023 State of Health in the EU \u2013 Portugal."},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.32385\/rpmgf.v35i4.12239"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-023-00777-y"},{"key":"e_1_3_4_69_1","unstructured":"OsMed. (n.d.). National report on medicines use in Italy 2017. 2017. https:\/\/www.aifa.gov.it\/documents\/20142\/241052\/OsMed_2017_eng.pdf"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2021.2219"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.01.036"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.2165\/11531570-000000000-00000"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1681"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.892"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.20344\/amp.20389"},{"key":"e_1_3_4_76_1","unstructured":"Public Health England. (2019). Dependence and withdrawal associated with some prescribed medicines \u2013 An evidence review. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/829777\/PHE_PMR_report.pdf"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.20986\/MPJ.2021.1005\/2021"},{"issue":"13","key":"e_1_3_4_78_1","first-page":"194","article-title":"Operacionaliza\u00e7\u00e3o para Portugal da Lista EU(7)-PIM para Identifica\u00e7\u00e3o de Medicamentos Potencialmente Inapropriados nos Idosos [Operationalisation for Portugal of the EU(7)-PIM list for identification of potentially inappropriate medicines in older adults]","volume":"33","author":"Rodrigues D. A.","year":"2020","unstructured":"Rodrigues, D. A., Herdeiro, M. T., Thurmann, P. A., Figueiras, A., Coutinho, P., & Roque, F. (2020). Operacionaliza\u00e7\u00e3o para Portugal da Lista EU(7)-PIM para Identifica\u00e7\u00e3o de Medicamentos Potencialmente Inapropriados nos Idosos [Operationalisation for Portugal of the EU(7)-PIM list for identification of potentially inappropriate medicines in older adults]. Acta M\u00e9dica Portuguesa, 33(13), 194\u2013200. www.actamedicaportuguesa.com","journal-title":"Acta M\u00e9dica Portuguesa"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1615-7"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.2010.00906.x"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-800634-4.00036-6"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci8040073"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-101868"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2531-4"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2020.110343"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.05.053"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.16261"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2018.02.022"},{"key":"e_1_3_4_89_1","unstructured":"Transnational Institute. (2015). The UN drug control conventions. https:\/\/www.tni.org\/en\/publication\/the-un-drug-control-conventions"},{"key":"e_1_3_4_90_1","unstructured":"United Nations Office on Drug and Crime. (2017a). World Drug Report 2017 Booklet 2 \u2013 GLOBAL OVERVIEW OF DRUG DEMAND AND SUPPLY. Retrieved April 30 2023 from www.unodc.org\/wdr2017"},{"key":"e_1_3_4_91_1","article-title":"Non-medical use of benzodiazepines: a growing threat to public health?","volume":"18","author":"United Nations Office on Drugs and Crime","year":"2017","unstructured":"United Nations Office on Drugs and Crime. (2017b). Non-medical use of benzodiazepines: a growing threat to public health? Global SMART Update, 18, 1-12, www.unodc.org\/unodc\/en\/","journal-title":"Global SMART Update"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.2174\/187447370801150611184218"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.1152"},{"key":"e_1_3_4_94_1","unstructured":"WHO Collaborating Centre for Drug Statistics and Methodology. (2022a). WHOCC \u2013 Structure and principles. Retrieved May 26 2023 from https:\/\/www.whocc.no\/atc\/structure_and_principles\/"},{"key":"e_1_3_4_95_1","unstructured":"WHO Collaboration Centre for Drug Statistics Methodology. (2022b). Guidelines for ATC classification and DDD assignment. https:\/\/www.whocc.no\/atc_ddd_index_and_guidelines\/guidelines\/"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14592"},{"key":"e_1_3_4_97_1","volume-title":"International classification of primary care","author":"World Health Organization","unstructured":"World Health Organization. (n.d.). International classification of primary care (2nd ed.). ICPC-2. Retrieved May 12, 2023, from https:\/\/www.who.int\/standards\/classifications\/other-classifications\/international-classification-of-primary-care.","edition":"2"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1177\/0193945913509692"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1532-2149.2014.496.x"}],"container-title":["Journal of Pharmaceutical Policy and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20523211.2024.2369319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:55:49Z","timestamp":1772722549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/20523211.2024.2369319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/20523211.2024.2369319"],"URL":"https:\/\/doi.org\/10.1080\/20523211.2024.2369319","relation":{},"ISSN":["2052-3211"],"issn-type":[{"value":"2052-3211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-03-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2369319"}}